Consistent with previous COVID‐19 biomarker studies, plasma concentrations of the proinflammatory adhesion molecules ICAM‐1, VCAM‐1, and E‐selectin were significantly elevated, and associated with disease severity.7 Here, ICAM1 is linked to COVID-19.